Daniel Hägi-Pedersen: Clinical Trials

4 trials sponsored by Daniel Hägi-Pedersen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 3, Terminated 1

Follow Daniel Hägi-Pedersen: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DEXRAR: DEXamethasone in Revision ARthroplasty
Dexamethasone, Saline isotonic - Pain, Postoperative
Phase 4TerminatedDaniel Hägi-Pedersen982017-05-312025-05-23
PAracetamol and NSAID in Combination: A Randomised, Blinded, Parallel, 4-group Clinical Trial
Paracetamol (1g x 4), Ibuprofen (400 mg x 4), Paracetamol (0,5 g x 4) - Pain, Postoperative
Phase 4CompletedDaniel Hägi-Pedersen5562015-11-012018-02-12
Effect of Nervus Cutaneous Femoris Lateralis-Blockade on Moderate Pain Responders After Total Hip Arthroplasty
Ropivacaine, Saline - Pain, Postoperative, Ropivacaine
Phase 4CompletedDaniel Hägi-Pedersen602015-01-012015-09-25
Effect of a Lateral Nerve of the Thigh Block on Postoperative Pain After Total Hip Replacement Surgery
Ropivacaine, Placebo, An ultrasound-guided Nervus cutaneous femoral lateralis blockade will be given postoperatively - Pain, Postoperative, Anesthesia, Conduction
Phase 4CompletedDaniel Hägi-Pedersen1002014-03-012014-11-13

Conditions studied

Pain, Postoperative (4)

Interventions

Ropivacaine (2)  ·  Sodium Chloride (2)  ·  Acetaminophen (1)  ·  Dexamethasone (1)  ·  Ibuprofen (1)

Countries

Denmark (3)

Top investigators

Kasper H Thybo, MD (1)  ·  Martin Pohlman, MD (1)  ·  Ole Mathiesen, MD, PhD (1)

Results publications

PMID 29017585, PMID 30747964

NIH funding

2014 (1), 2015 (1), 2016 (1)